Lamivudine Therapy for Decompensated Liver Cirrhosis Related to Hepatitis B Virus Infection

Publisher： Karger

E-ISSN： 1423-0100|46|6|388-393

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.6, 2003-12, pp. : 388-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient with decompensated hepatitis C virus–related cirrhosis delisted for liver transplantation after successful sofosbuvir‐based treatment

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 3, 2015-03 ,pp. : 408-409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Benefit of Lamivudine Therapy and Factors Associated with Clinical Outcome in Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B Virus Infection

By  

Intervirology, Vol. 47, Iss. 6, 2004-11 ,pp. : 335-341

Karger

Access to resources Recommend Favorite

Efficacy of Lamivudine Therapy and Factors Associated with Emergence of Resistance in Chronic Hepatitis B Virus Infection in Japan

By  

Intervirology, Vol. 46, Iss. 3, 2003-07 ,pp. : 182-189

Karger

Access to resources Recommend Favorite

Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 897-904

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1809-1820

John Wiley & Sons Inc

Access to resources Recommend Favorite